D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$591M |
| 2 |
NVIDIA
NVDA
|
+$454M |
| 3 |
EQT Corp
EQT
|
+$361M |
| 4 |
Citigroup
C
|
+$332M |
| 5 |
CELG
Celgene Corp
CELG
|
+$315M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$618M |
| 2 |
Dell
DELL
|
+$463M |
| 3 |
IBM
IBM
|
+$331M |
| 4 |
Amgen
AMGN
|
+$284M |
| 5 |
Johnson & Johnson
JNJ
|
+$250M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 13.01% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Financials | 10.39% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Heidrick & Struggles
HSII
$1.03B
| $982K | ﹤0.01% |
31,436
-21,614
| -41% | -$675K |
|
1777
Turkcell
TKC
$4.78B
| $980K | ﹤0.01% |
102,503
-19,897
| -16% | -$190K |
|
|
TYPE
1778
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $980K | ﹤0.01% |
43,669
+14,410
| +49% | +$323K |
|
|
OMED
1779
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $976K | ﹤0.01% |
306,763
+25,833
| +9% | +$82.2K |
|
1780
McEwen Inc.
MUX
$732M
| $974K | ﹤0.01% |
46,815
-118,988
| -72% | -$2.48M |
|
1781
Qorvo
QRVO
$8.04B
| $974K | ﹤0.01% |
13,824
-31,105
| -69% | -$2.19M |
|
1782
Corcept Therapeutics
CORT
$7.67B
| $969K | ﹤0.01% |
58,928
-62,997
| -52% | -$1.04M |
|
1783
Ryman Hospitality Properties
RHP
$6.4B
| $968K | ﹤0.01% |
12,502
-42,230
| -77% | -$3.27M |
|
1784
LSI Industries
LYTS
$683M
| $967K | ﹤0.01% |
119,194
-45,709
| -28% | -$371K |
|
1785
Royal Gold
RGLD
$12.3B
| $965K | ﹤0.01% |
11,241
+252
| +2% | +$21.6K |
|
1786
IDT Corp
IDT
$1.64B
| $963K | ﹤0.01% |
153,590
+16,725
| +12% | +$105K |
|
1787
Heritage Commerce
HTBK
$629M
| $961K | ﹤0.01% |
58,307
+1,652
| +3% | +$27.2K |
|
1788
UNIFI
UFI
$84.1M
| $957K | ﹤0.01% |
26,411
-3,287
| -11% | -$119K |
|
1789
Helmerich & Payne
HP
$2.06B
| $954K | ﹤0.01% |
14,336
+4,148
| +41% | +$276K |
|
|
HCOM
1790
DELISTED
Hawaiian Telcom Holdco, Inc
HCOM
| $953K | ﹤0.01% |
35,701
+753
| +2% | +$20.1K |
|
1791
Tilly's
TLYS
$60.6M
| $952K | ﹤0.01% |
84,289
-111,783
| -57% | -$1.26M |
|
1792
Graham Corp
GHM
$542M
| $942K | ﹤0.01% |
43,982
-9,988
| -19% | -$214K |
|
1793
Prosperity Bancshares
PB
$6.38B
| $938K | ﹤0.01% |
12,909
+4,610
| +56% | +$335K |
|
1794
Harmonic Inc
HLIT
$1.14B
| $934K | ﹤0.01% |
245,756
+23,627
| +11% | +$89.8K |
|
1795
Agnico Eagle Mines
AEM
$76.7B
| $931K | ﹤0.01% |
22,120
-6,904
| -24% | -$291K |
|
1796
Powell Industries
POWL
$3.51B
| $931K | ﹤0.01% |
34,680
-1,828
| -5% | -$49.1K |
|
1797
B2Gold
BTG
$5.81B
| $930K | ﹤0.01% |
340,840
-317,033
| -48% | -$865K |
|
1798
Medical Properties Trust
MPW
$2.75B
| $930K | ﹤0.01% |
71,508
-416,447
| -85% | -$5.42M |
|
1799
Standex International
SXI
$2.52B
| $929K | ﹤0.01% |
9,747
+2,550
| +35% | +$243K |
|
1800
Aptevo Therapeutics
APVO
$4.87M
| $927K | ﹤0.01% |
1
| – | – |
|